会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
    • 包含N-末端胆碱结合蛋白的氨基酸的截短的多肽,来源于其的疫苗及其用途
    • US20050208069A1
    • 2005-09-22
    • US11032644
    • 2005-01-10
    • Elaine TuomanenTheresa WizemannH. MasureLeslie JohnsonScott Koenig
    • Elaine TuomanenTheresa WizemannH. MasureLeslie JohnsonScott Koenig
    • A61K38/00A61K39/00A61P31/04C07K14/315C12Q1/68A61K39/02C07H21/04C12N15/74
    • C07K14/3156A61K38/00A61K39/00
    • This invention provides an isolated polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate in which the amino acid sequence is set forth in any of SEQ ID NOS: 1, 3-7, or 9-11, including fragments, mutants, variants, analogs, or derivatives, thereof. Also, this invention provides a isolated polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate, wherein the amino acid is set forth in SEQ ID NO: 24, wherein the polypeptide retains its native tertiary structure and methods of preparation. This invention provides an isolated polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate, wherein the polypeptide has lectin activity and does not bind to choline. This invention provides an isolated immunogenic polypeptide comprising an amino acid sequence of a N— terminal choline binding protein A truncate. This invention provides an isolated nucleic acid encoding a polypeptide comprising an amino acid sequence of a N— terminal choline binding protein A truncate. Lastly, this invention provides pharmaceutical compositions, vaccines, and diagnostic and therapeutic methods of use.
    • 本发明提供了分离的多肽,其包含N-末端胆碱结合蛋白A截短物的氨基酸序列,其中氨基酸序列在SEQ ID NO:1,3-7或9-11中任一项所述,包括片段 ,突变体,变体,类似物或衍生物。 此外,本发明提供了包含N-末端胆碱结合蛋白A截短物的氨基酸序列的分离的多肽,其中所述氨基酸如SEQ ID NO:24所示,其中所述多肽保留其天然三级结构和制备方法 。 本发明提供了分离的多肽,其包含N-末端胆碱结合蛋白A截短物的氨基酸序列,其中所述多肽具有凝集素活性并且不与胆碱结合。 本发明提供了分离的免疫原性多肽,其包含N-末端胆碱结合蛋白A截短体的氨基酸序列。 本发明提供编码包含N-末端胆碱结合蛋白A截短物的氨基酸序列的多肽的分离的核酸。 最后,本发明提供药物组合物,疫苗以及诊断和治疗使用方法。